Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Does diabetes affect the brain? new study investigates thinking and emotions in youth with type 1 diabetes

NCT ID NCT07164768

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

Researchers in India are studying how type 1 diabetes affects thinking, memory, and mental health in children and young adults aged 10 to 21. They will compare 264 youth with type 1 diabetes to 132 healthy peers using tests of intelligence, attention, memory, and emotional well-being. This observational study aims to fill a gap in understanding diabetes' impact on the developing brain in India, where the condition is becoming more common.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal how type 1 diabetes affects thinking and emotional well-being in Indian youth, guiding future support and interventions.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study Subjects: The Hirabai Cowasji Jehangir Medical Research Institute, which is a sister concern of Jehangir hospital, Pune, has been involved in health related programs since its inception in 1995. Our major areas of work include Nutritional and Growth Disorders in Children, Type 1 Diabetes, Maternal and Child Health, Osteoporosis and Bone Health, Psychological Counseling, HIV and Cancers. Cases: There are 738 children registered with HCJMRI for the treatment and management of type 1 diabetes. The 'Sweetlings' programme is a charity clinic that provides holistic care to underprivileged children and youth with Type 1 Diabetes Mellitus (T1D). Currently, the clinic supports 548 children and youth with T1D aged 0 to 22 years in the Pune region of the Western Indian State of Maharashtra. From these, we have 386 children who are between 10-21 years of age. Controls: Siblings of these T1D children will be included as healthy age-matched controls for participation in this study. This wil

Ages

10 to 21 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children, adolescents and young adults with T1D and their parents (caregiver, either mother or father) Exclusion Criteria: * Both parents are not alive or the child is not living with the parents and living with the grandparents.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes (T1D) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hirabai Cowasji Jehangir Medical Research Institute

    Pune, Maharashtra, 411001, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.